VVD-9546

N/A

Report date: 2025/01/26 16:27:49
NME

Base Information

Drug NameVVD-9546
Drug Alias Nameubiquitin proteasome modulators (Vividion/Bristol-Myers Squibb)ubiquitin proteasome modulators (Vividion/Celgene)VVD-9546
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProteasome modulators
TargetsProteasome
Therapy Area/IndicationsNerve DegenerationInflammationNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVividion Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesVividion Therapeutics IncBristol-Myers Squibb Company
Inactive CompaniesCelgene Corp
Active IndicationsNerve DegenerationInflammationNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A